The global overactive bladder treatment market, valued at USD 2.73 billion in 2023, is projected to grow at a steady compound annual growth rate (CAGR) of 2.96% during the forecast period from 2024 to 2031, reaching USD 3.44 billion by the end of 2031.
Overactive bladder (OAB) is a common urological condition characterized by symptoms such as urinary urgency, frequent urination, and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian